ARC-152

N/A

Report date: 2026/03/19 17:12:08

Base Information

Drug NameARC-152

Drug Alias NameARC152ARC-152

ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers

Mechanisms of ActionAnti-CD28

TargetsT-cell-specific surface glycoprotein CD28

Therapy Area/IndicationsGastrointestinal Neoplasms

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesThird Arc Bio Inc

China Registration ClassN/A

Develop Information

Active CompaniesThird Arc Bio Inc

Inactive CompaniesN/A

Active IndicationsGastrointestinal Neoplasms

Inactive IndicationsN/A

Other Information

ATC CodeN/A